Mupirocin Resistance in Patients Colonized with Methicillin-Resistant Staphylococcus aureus in a Surgical Intensive Care Unit
Author(s) -
Jerrilyn Jones,
Thomas J. Rogers,
P. Brookmeyer,
William M. Dunne,
Gregory A. Storch,
Craig M. Coopersmith,
Victoria J. Fraser,
David K. Warren
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/520663
Subject(s) - mupirocin , medicine , staphylococcus aureus , methicillin resistant staphylococcus aureus , microbiology and biotechnology , intensive care unit , micrococcaceae , staphylococcal infections , context (archaeology) , antibacterial agent , antibiotics , surgery , bacteria , biology , paleontology , genetics
Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) can be a precursor to serious infection, and decolonization with topical mupirocin has been studied as a means of preventing clinical infection. Mupirocin resistance in patients with MRSA has been reported, usually in the context of widespread mupirocin use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom